6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridine, 97.0%, 25g

Ethyl 5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1H-indole-2-carboxylate, 97%, 500mg

EDTA dipotassium salt dihydrate, min. 99%, for synthesis, 5 kg, plastic packaging.

(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide, 98%, 100mg

2,4-Dichlorothieno[3,2-d]pyrimidine>98.0%(GC)1g

Methyl (3-bromophenyl)carbamate, 95.0%, 2g

Bis(tetrabutylammonium) Bis(1,3-dithiole-2-thione-4,5-dithiolato)zinc Complex [Organic Electronic Material]>98.0%(N)(T)25g

4-Chloro-2'-methylbenzophenone, 97.0%, 1g

4-((4-Ethyl-2,6-difluorophenyl)ethynyl)-4'-propyl-1,1'-biphenyl, 97%, 250mg

Potassium Tetraphenylborate>97.0%(HPLC)(T)5g

1-(2-Chloro-3-fluoropyridin-4-yl)ethanone, 97%, 1g

3-(BOC-AMINOMETHYL)-3-METHYLAZETIDINE HCL, 95.0%, 10g

1-Bromo-2-(bromomethyl)naphthalene, 96.0%, 25g